- ToleRability of BevacizUmab in elderly Ovarian cancer patients (TURBO study): a case-control study of a real-life experience
-
Amadio G, Marchetti , Villani ER, Fusco D, Stollagli , Bottoni C, Distefano , Colloca G, Scambia G, Fagotti A
- KMID: 2500405
- J Gynecol Oncol.
- 2020 Jan;31(1):e6.
- doi: 10.3802/jgo.2020.31.e6
Objective: Bevacizumab maintenance following platinum-based chemotherapy is an effective treatment for epithelial ovarian cancer (EOC), both in primary and recurrent disease. Our aim was to identify criteria to select elderly... -
- CITED
-
- Close
- SHARE
-
- Close
- High Efficacy and Safety of Flat-Dose Ribavirin Plus Sofosbuvir/Daclatasvir in Genotype 3 Cirrhotic Patients
-
Pellicelli A, Messina V, Giannelli , Distefano , Palitti VP, Vignally P, Tarquini P, Izzi A, Moretti A, Babudieri , Dell’Isola S, Marignani , Scifo G, Iovinella , Cariti G, Pompili M, Candilo FD, Fontanella L, Ettorre GM, Vennarecci G, Ippolito A, Barbarini
- KMID: 2500540
- Gut Liver.
- 2020 May;14(3):357-367.
- doi: 10.5009/gnl18269
Background/Aims: Patients with genotype 3 hepatitis C virus (G3-HCV) cirrhosis are very difficult to treat compared to patients with other HCV genotypes. The optimal treatment duration and drug regimen associated... -
- CITED
-
- Close
- SHARE
-
- Close
